NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1659367175 M.D.
Verify on CMS → Indira Sastry, M.D.
Pulmonary Disease Physician in Shreveport, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
625
Medicare Part D claims · 86 beneficiaries · Pulmonary Disease Physician avg: 1K
Industry payments
$179.92
8 payments · CMS Open Payments (Sunshine Act)
What the federal data shows
Indira Sastry, M.D. filed 625 Medicare Part D claims in 2024 as a Pulmonary Disease Physician in Shreveport, Louisiana.
- 625
- Part D claims, 2024
- $179.92
- industry payments (Sunshine Act)
- ≥68th
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Indira Sastry, M.D.
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1659367175), first enumerated 09/20/2005.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 625 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$179.92 in reported industry payments (8 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1659367175 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1659367175
- ENUM-LEGACY 2005
- TAX-MID 10K Pulmonary Disease
- RX-LIGHT 625
- BOOK-THIN 140 in Louisiana
- PHOTO-ENUM Richard Baron · 2005
Indira Sastry, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
625 ≥ 68th percentile 68% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Indira Sastry, M.D. practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Indira Sastry, M.D.?
Quality data not reportedPrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
625 58% vs specialty avg
Specialty distribution in Louisiana
How Pulmonary Disease Physician compares to other specialties among Louisiana providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Pulmonary Disease Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1659367175 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | M.D. |
| Gender | Female |
| NPI Issued | 09/20/2005 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Indira Sastry, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$180
Largest payer
GENZYME CORPORATION
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
625
Total Claims
$162K
Total Drug Cost
86
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 915.5
- Total Day Supply
- 25,595
- Generic Drug Cost
- $9K
- Antibiotic Claims
- 44
Patient Demographics
- Average Patient Age
- 74.0 years
- Avg HCC Risk Score
- 1.73
- Gender Split
- 62% female / 38% male
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Indira Sastry, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Trelegy Ellipta
Trelegy Ellipta
168 claims
- Albuterol Sulfate … 61
Albuterol Sulfate Hfa
61 claims
- Cefuroxime 33
Cefuroxime
33 claims
- Fluticasone Propio… 28
Fluticasone Propionate
28 claims
- Fluticasone-Salmet… 26
Fluticasone-Salmeterol
26 claims
- Celecoxib 22
Celecoxib
22 claims
- Levalbuterol Tartr… 22
Levalbuterol Tartrate Hfa
22 claims
- Breo Ellipta 20
Breo Ellipta
20 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 168 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 61 |
| Cefuroxime Cefuroxime Axetil | 33 |
| Fluticasone Propionate | 28 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 26 |
| Celecoxib | 22 |
| Levalbuterol Tartrate Hfa Levalbuterol Tartrate | 22 |
| Breo Ellipta Fluticasone/Vilanterol | 20 |
| Desloratadine | 20 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 17 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Indira Sastry, M.D. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Indira Sastry, M.D.'s 625 claims are below the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Sastry, both outside Louisiana so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2005)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Sastry.
One of 140 Pulmonary Disease Physician providers enrolled in Louisiana, 5 are shown here.
Dr. Ramsy Abdelghani
M.D.
New Orleans, LA
Dr. Mostafa Aboubakr
MD
Baton Rouge, LA
Dr. Cesar Aguilar Lopez
M.D
New Orleans, LA
Dr. Juzar Ali
MD.,FRCP., FCCP(C)
New Orleans, LA
Dr. Sana Ali
MD
Opelousas, LA
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Indira Sastry, M.D.'s specialty? ▼
Indira Sastry, M.D. specializes in Pulmonary Disease Physician and practices in Shreveport, Louisiana. Credentials: M.D..
How much does Indira Sastry, M.D. prescribe under Medicare Part D? ▼
In 2024, Indira Sastry, M.D. wrote 625 Medicare Part D claims totaling $162K in drug costs for 86 beneficiaries.
Where is Indira Sastry, M.D. located? ▼
Indira Sastry, M.D. is located at 1666 E BERT KOUNS LOOP, Shreveport, LA, 71105. Phone: (318) 797-7696.
What is Indira Sastry, M.D.'s NPI number? ▼
Indira Sastry, M.D.'s National Provider Identifier (NPI) is 1659367175, issued on 09/20/2005.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Indira Sastry, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Indira Sastry, M.D.'s most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Cefuroxime. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Indira Sastry, M.D. accept Medicare? ▼
Indira Sastry, M.D. appears in CMS Medicare data with 625 Part D claims and 86 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Indira Sastry, M.D.'s credentials? ▼
Indira Sastry, M.D.'s NPI is 1659367175 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.